• [stock-market-ticker symbols="AAPL;MSFT;GOOG;HPQ;^SPX;^DJI;LSE:BAG" stockExchange="NYSENasdaq" width"100%" palette="financial-light"]

    Ivermectin Reduces Mortality Rate From COVID-19 By 92% With Regular Use

    September 2, 2022
    No Comments
    Image by Bundesministerium für Finanzen

    Please Follow us on Gab, Minds, Telegram, Rumble, Gab TV, GETTR, Truth Social    

    In a strictly controlled study of over 88,000 individuals, a new peer-reviewed study found a direct relationship between the dose of ivermectin and the level of protection against COVID-19. 

    The second phase of the study was completed and published in the Cureus Journal of Medical Science this week. 

    The study found “that participants taking regular prophylactic doses of ivermectin had lower rates of infections, hospitalizations, and deaths than those not taking ivermectin regularly,“ read a statement from Front Line COVID-19 Critical Care Alliance. 

    The study also demonstrated “a direct relationship between the dose of ivermectin and the level of protection the drug provides. Test subjects that took higher doses of ivermectin for two consecutive days per week for at least six weeks had a 92% reduction in death from COVID-19,” according to the study results.

    “We showed a dose-response effect, that is, the more you used, the more protection you had, which reinforces our previous conclusions regarding ivermectin efficacy,” said Flavio Cadegiani, M.D., co-author of the study, Founder and CEO, Corpometria Institute, Brazil and member of the Front Line COVID-19 Critical Care Alliance (FLCCC). “We used a large sample of almost 90,000 people in strictly controlled conditions and let the data lead us. The results are hard to refute.”

    ‘NO AD’ subscription for CDM!  Sign up here and support real investigative journalism and help save the republic!‘

    The study was conducted in the Brazilian city of Itajaí between July 2020 and December 2020 as part of a citywide program to distribute ivermectin as a prophylaxis against the SARS-CoV-2 virus. 

    “We are very proud of Dr. Cadegiani and his colleagues for the work they did on this study,” said Paul E. Marik, M.D., FCCM, FCCP, founding member of the FLCCC and former Chief, Pulmonary and Critical Care Medicine at Eastern Virginia Medical School. “The design and administration of this study resulted in a large amount of reliable data that shows, once again, there is no doubt that ivermectin is highly effective as a safe prophylaxis and treatment for COVID-19.”

    Front Line COVID-19 Critical Care Alliance can be found www.flccc.net.

    The published research can be found here



    Christine Dolan

    Christine Dolan is a seasoned Investigative Journalist, television producer, author, and photographer. She is Co-Founder of American Conversations whose format focuses on in-depth analysis of critical issues about “the story behind the headlines.”
  • Subscribe
    Notify of

    Inline Feedbacks
    View all comments


  • Subscribe to our evening newsletter to stay informed during these challenging times!!